Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Roper

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
MMWR. Morbidity and Mortality Weekly Report|October 12, 2023
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023Katherine E Fleming-Dutra, Jefferson M Jones, Lauren E Roper, et al.
MMWR. Morbidity and Mortality Weekly Report|November 10, 2022
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022Hannah G Rosenblum, Megan Wallace, Monica Godfrey, et al.
MMWR. Morbidity and Mortality Weekly Report|August 4, 2022
Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years - United States, July 2022Evelyn Twentyman, Megan Wallace, Lauren E Roper, et al.
MMWR. Morbidity and Mortality Weekly Report|June 30, 2022
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022Katherine E Fleming-Dutra, Megan Wallace, Danielle L Moulia, et al.
MMWR. Morbidity and Mortality Weekly Report|December 8, 2022
Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons - 43 U.S. Jurisdictions, July 31-October 1, 2022Amanda B Payne, Logan C Ray, Matthew M Cole, et al.
Vaccine|January 4, 2025
A framework for monitoring RSV prevention product effectiveness in the United StatesLauren E Roper, Ruth Link-Gelles, Diya Surie, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
MMWR. Morbidity and Mortality Weekly Report|October 12, 2023
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023Katherine E Fleming-Dutra, Jefferson M Jones, Lauren E Roper, et al.
MMWR. Morbidity and Mortality Weekly Report|November 10, 2022
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022Hannah G Rosenblum, Megan Wallace, Monica Godfrey, et al.
MMWR. Morbidity and Mortality Weekly Report|August 4, 2022
Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years - United States, July 2022Evelyn Twentyman, Megan Wallace, Lauren E Roper, et al.
MMWR. Morbidity and Mortality Weekly Report|June 30, 2022
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022Katherine E Fleming-Dutra, Megan Wallace, Danielle L Moulia, et al.
MMWR. Morbidity and Mortality Weekly Report|December 8, 2022
Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons - 43 U.S. Jurisdictions, July 31-October 1, 2022Amanda B Payne, Logan C Ray, Matthew M Cole, et al.
Vaccine|January 4, 2025
A framework for monitoring RSV prevention product effectiveness in the United StatesLauren E Roper, Ruth Link-Gelles, Diya Surie, et al.
Pageof 6